Pursuant to section 3719.41 of the Revised Code, controlled substance schedule II is hereby established, which schedules include the following, subject to amendment pursuant to section 3719.43 or 3719.44 of the Revised Code.
(A) Narcotics-opium and opium derivatives Unless specifically excepted under federal drug abuse control laws or unless listed in another schedule, any of the following substances whether produced directly or indirectly by extraction from substances of vegetable origin, independently by means of chemical synthesis, or by a combination of extraction and chemical synthesis:
(1) Opium and opiate, and any salt, compound, derivative, or preparation of opium or opiate excluding apomorphine, thebaine-derived butorphanol, dextrorphan, nalbuphine, naldemedine, nalmefene, naloxegol, naloxone, and naltrexone, and their respective salts, but including the following: (c) Opium fluid extracts;(j) Etorphine hydrochloride;(2) Any salt, compound, derivative, or preparation thereof that is chemically equivalent to or identical with any of the substances referred to in paragraph (A)(1) of this rule, except that these substances shall not include the isoquinoline alkaloids of opium; (3) Opium poppy and poppy straw;(4) Coca leaves and any salt, compound, derivative, or preparation of coca leaves (including cocaine and ecgonine, their salts, isomers, and derivatives, and salts of those isomers and derivatives), and any salt, compound, derivative, or preparation thereof that is chemically equivalent to or identical with any of these substances, except that the substances shall not include: (a) Decocainized coca leaves or extraction of coca leaves, which extractions do not contain cocaine or ecgonine; or(5) Concentrate of poppy straw (the crude extract of poppy straw in either liquid, solid, or powder form that contains the phenanthrene alkaloids of the opium poppy). (B) Narcotics-opiates Unless specifically excepted under federal drug abuse control laws or unless listed in another schedule, any of the following opiates, including their isomers, esters, ethers, salts, and salts of isomers, esters, and ethers, whenever the existence of these isomers, esters, ethers, and salts is possible within the specific chemical designation, but excluding dextrorphan and levopropoxyphene:
(5) Bulk dextropropoxyphene (non-dosage forms);(11) Levo-alphacetylmethadol (some other names: levo-alpha-acetylmethadol; levomethadyl acetate; LAAM);(16) Methadone-intermediate, 4-cyano-2-dimethylamino-4,4-diphenyl butane;(17) Moramide-intermediate, 2-methyl-3-morpholino-1,1-diphenylpropane-carboxylic acid;(18) Pethidine (meperidine);(19) Pethidine-intermediate-A, 4-cyano-1-methyl-4-phenylpiperidine;(20) Pethidine-intermediate-B, ethyl-4-phenylpiperidine-4-carboxylate;(21) Pethidine-intermediate-C, 1-methyl-4-phenylpiperidine-4-carboxylic acid;(C) Stimulants Unless specifically excepted under federal drug abuse control laws or unless listed in another schedule, any material, compound, mixture, or preparation that contains any quantity of the following substances having a stimulant effect on the central nervous system:
(1) Amphetamine, its salts, its optical isomers, and salts of its optical isomers;(2) Methamphetamine, its salts, its isomers, and salts of its isomers;(4) Phenmetrazine and its salts;(5) Lisdexamfetamine, its salts, isomers, and salts of its isomers.(D) Depressants Unless specifically excepted under federal drug abuse control laws or unless listed in another schedule, any material, compound, mixture, or preparation that contains any quantity of the following substances having a depressant effect on the central nervous system, including their salts, isomers, and salts of isomers, whenever the existence of these salts, isomers, and salts of isomers is possible within the specific chemical designation:
(4) Phencyclidine (some trade or other names: 1-(1-phenylcyclohexyl)piperidine; PCP);(6) 1-aminophenylcyclohexane and all N-mono-substituted and/or all N-N-disubstituted analogs including, but not limited to, the following: (a) 1-phenylcyclohexylamine;(b) (1-phenylcyclohexyl) methylamine;(c) (1-phenylcyclohexyl) dimethylamine;(d) (1-phenylcyclohexyl) methylethylamine;(e) (1-phenylcyclohexyl) isopropylamine;(f) 1-(1-phenylcyclohexyl) morpholine.(E) Hallucinogenic substances (1) Nabilone (another name for nabilone: (+)-trans-3-(1,1-dimethylheptyl)-6,6a,7,8,10,10a- hexahydro-1- hydroxy-6,6-dimethyl-9H-dibenzo[b,d]pyran-9-one);(2) Dronabinol [(-)-delta-9-trans tetrahydrocannabinol] in an oral solution in a dangerous drug approved for marketing by the U.S. food and drug administration.(F) Immediate precursors Unless specifically excepted under federal drug abuse control laws or unless listed in another schedule, any material, compound, mixture, or preparation that contains any quantity of the following substances:
(1) Immediate precursor to amphetamine and methamphetamine: Phenylacetone (some trade or other names: phenyl-2-propanone; P2P; benzyl methyl ketone; methyl benzyl ketone);
(2) Immediate precursors to phencyclidine (PCP): (a) 1-phenylcyclohexylamine;(b) 1-piperidinocyclohexanecarbonitrile (PCC).(3) Immediate precursor to fentanyl: 4-anilino-N-phenethylpiperidine (ANPP).
Replaces: 4729-11-03
Ohio Admin. Code 4729:9-1-02
Five Year Review (FYR) Dates: 4/23/2024 and 04/23/2029
Promulgated Under: 119.03
Statutory Authority: 4729.26, 3719.28, 3719.41
Rule Amplifies: 3719.43, 3719.44
Prior Effective Dates: 09/01/2014, 03/22/2020Effective: 3/22/2020
Five Year Review (FYR) Dates: 03/22/2025
Promulgated Under: 119.03
Statutory Authority: 4729.26, 3719.28, 3719.41
Rule Amplifies: 3719.43, 3719.44
Prior Effective Dates: 09/01/2014